Last €58.34 EUR
Change Today +0.09 / 0.15%
Volume 0.0
CLH On Other Exchanges
New York
As of 1:59 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

cardinal health inc (CLH) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/9/14 - €58.67
52 Week Low
09/30/13 - €38.41
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CARDINAL HEALTH INC (CLH)

cardinal health inc (CLH) Related Businessweek News

View More BusinessWeek News

cardinal health inc (CLH) Details

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers. This segment offers distribution, inventory management, data reporting, new product launch support, and contract pricing and chargeback administration services to pharmaceutical manufacturers; operates nuclear pharmacies and cyclotron facilities that manufacture, prepare, and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; provides pharmacy services to hospitals and other healthcare facilities; and offers logistics, marketing, and other services. This segment also provides various consulting and other services to pharmaceutical manufacturers, third-party payors, and healthcare providers. The Medical segment distributes a range of medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices, and other healthcare providers; and offers supply chain services, including spend, distribution, and inventory management services to healthcare providers. This segment also develops, manufactures, and sources a line of private brand medical and surgical products comprising surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems, as well as sterile and non-sterile procedure kits directly or through third-party distributors. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

34,000 Employees
Last Reported Date: 08/13/14
Founded in 1979

cardinal health inc (CLH) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.3M
Chief Financial Officer
Total Annual Compensation: $756.9K
Chief Executive Officer of Pharmaceutical Seg...
Total Annual Compensation: $647.7K
Chief Executive Officer of Medical Segment
Total Annual Compensation: $647.7K
Chief Legal and Compliance Officer
Total Annual Compensation: $508.5K
Compensation as of Fiscal Year 2014.

cardinal health inc (CLH) Key Developments

Cardinal Health, Inc. Announces Executive Changes

Cardinal Health announced that Michael C. Kaufmann has been named chief financial officer of the company effective Nov. 11, 2014. This follows the previously announced planned retirement of current Chief Financial Officer Jeffrey W. Henderson. Jon Giacomin has been named to the role of chief executive officer of the Pharmaceutical segment, currently held by Mike Kaufmann, also effective Nov. 11, 2014. Kaufmann has served in the role of chief executive officer of Cardinal Health's Pharmaceutical segment since 2009. He joined Cardinal Health in 1990 and held a number of senior operational, sales and finance positions. Jon Giacomin to lead Pharmaceutical segment. A 12-year veteran of Cardinal Health, Giacomin currently serves as president of U.S. Pharmaceutical Distribution. To ensure a seamless transition, current Cardinal Health CFO Jeff Henderson will remain as an employee until his retirement just past the end of the fiscal year in August 2015. He will continue to have oversight for Cardinal Health China, in addition to working with the Cardinal Health leadership team on significant initiatives.

Fred's, Inc. and Cardinal Health, Inc. Announce Primary Supply Agreement

Fred's, Inc. and Cardinal Health, Inc. announced a multi-year agreement for Cardinal Health to be the new primary supplier of branded and generic pharmaceutical products to all of Fred's more than 360 in-store pharmacies and EIRIS Health Services in the United States. Under the agreement, Fred's and Cardinal Health will establish a mutually beneficial strategic alliance designed to support Fred's key initiative of rapid pharmacy growth, and build on a foundation of premier supply chain and asset management tools.

Cardinal Health, Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 08:00 AM

Cardinal Health, Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 08:00 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Jeffrey W. Henderson, Chief Financial Officer.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLH:GR €58.34 EUR +0.09

CLH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $77.13 USD +0.60
Celesio AG €26.51 EUR +0.02
Express Scripts Holding Co $74.60 USD +0.67
McKesson Corp $196.00 USD +0.46
Walgreen Co $63.18 USD -0.55
View Industry Companies

Industry Analysis


Industry Average

Valuation CLH Industry Range
Price/Earnings 22.2x
Price/Sales 0.3x
Price/Book 3.9x
Price/Cash Flow 18.1x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDINAL HEALTH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at